Dna X (SONM) Depreciation & Amortization (CF) (2018 - 2025)
Dna X filings provide 8 years of Depreciation & Amortization (CF) readings, the most recent being $1.5 million for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) rose 63.68% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 20.89% increase, with the full-year FY2025 number at $4.3 million, up 20.89% from a year prior.
- Depreciation & Amortization (CF) hit $1.5 million in Q4 2025 for Dna X, up from $952000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.8 million in Q4 2022 to a low of $67000.0 in Q3 2023.
- Median Depreciation & Amortization (CF) over the past 5 years was $713500.0 (2023), compared with a mean of $728350.0.
- Biggest five-year swings in Depreciation & Amortization (CF): crashed 71.84% in 2022 and later surged 1270.15% in 2024.
- Dna X's Depreciation & Amortization (CF) stood at $498000.0 in 2021, then skyrocketed by 265.46% to $1.8 million in 2022, then plummeted by 47.47% to $956000.0 in 2023, then dropped by 4.39% to $914000.0 in 2024, then skyrocketed by 63.68% to $1.5 million in 2025.
- The last three reported values for Depreciation & Amortization (CF) were $1.5 million (Q4 2025), $952000.0 (Q3 2025), and $797000.0 (Q2 2025) per Business Quant data.